| Revenue growth | FY27 guided at ₹2,200-2,400cr. |
|---|---|
| Margins | Targeting 12-14% EBITDA for FY27 vs 5% in Q4. |
| Order book | Large order book across businesses; 300 MT Ethyl Vanillin for Q1. |
| Demand visibility | Strong order book for Ethyl Vanillin; 50% of campaign covered. |
| Management confidence | High on Blends and Vanillin scaling despite macro headwinds. |
Growth
FY26 revenue reached ₹1,723cr; Blends grew 17% (18% including Europe). Q4 EBITDA at ₹21cr (5% margin).
Outlook
FY27 revenue guidance ₹2,200-2,400cr with 12-14% EBITDA margins. Vanillin volume target 2,200-2,400 MT for U.S.
Risks
Geopolitical conflicts causing 20% shipment delays, high freight costs, and raw material (Phenol/Caustic) price spikes.
Earnings Call filed with BSE, NSE: CAMLINFINE. Summary written with AI assistance from the document.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹94.49
- Market cap
- ₹1,815 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 308.6×Sector 37.2×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences filed a Postal Ballot Notice seeking approval to appoint Mr. Atul Pradhan as Non-Executive Independent Director. E-voting runs September 17 to October 16, 2026.
Camlin Fine Sciences Management Change
Camlin Fine Sciences appointed Mr. Atul Pradhan as Additional Non-Executive Independent Director effective September 11, 2026. The appointment is subject to shareholder approval via postal ballot.
Camlin Fine Sciences Earnings Call Transcript: Key Takeaways
Camlin Fine Sciences reported Q1 FY27 revenue of INR 5,199 million, up 28% YoY, though EBITDA margins were pressured to 4% by high raw material and freight costs.
- Call
- Guides 25% growth
Camlin Fine Sciences Investor Presentation: Key Takeaways
Camlin Fine Sciences reported record quarterly revenue of Rs 5,199 Mn for Q1FY27, up 27.5% YoY, driven by strong growth in Specialty Ingredients and Aroma segments.
Camlin Fine Sciences Q1 FY27 Results: Net Loss of ₹33.6 Cr, Loss Widens
Camlin Fine Sciences Ltd reported revenue from operations of ₹519.9 Cr (+27.5% YoY) and a net loss of ₹33.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹33.6 Cr
Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences Limited held its 33rd Annual General Meeting on August 11, 2026. All resolutions proposed in the notice were passed by the shareholders.